Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

TCT 2021 | Stem cell transplantation & cellular therapy during COVID-19 in Europe

Per Ljungman • 5 Feb 2021
TCT 2021
General

Per Ljungman, MD, PhD, Karolinska Institute, Stockholm, Sweden, outlines the impact of the COVID-19 pandemic on stem cell transplantation and cellular therapies in Europe over the last year and reports COVID-19 related mortality in patients undergoing stem cell transplantation and treated with CAR T-cell therapies. Prof. Ljungman highlights risk factors associated with COVID-19 mortality in this patient population, including age, poor performance status, and time from transplant. This interview took place during the Transplantation & Cellular Therapy (TCT) 2021 Meetings.

More from Per Ljungman

Drug-drug interaction management with the novel anti-CMV agents letermovir and maribavir
1:00
Drug-drug interaction management with the novel anti-CMV agents letermovir and maribavir
Per Ljungman • 1 Apr 2025
Does CMV remain a concern when performing transplantation in 2025?
1:00
Does CMV remain a concern when performing transplantation in 2025?
Per Ljungman • 1 Apr 2025
The updated ECIL guidelines for the management of CMV
1:15
The updated ECIL guidelines for the management of CMV
Per Ljungman • 1 Apr 2025
What to expect from TCT 2021?
0:27
What to expect from TCT 2021?
Per Ljungman • 5 Feb 2021

Related Videos

The ethical challenges of AI in hematology: patient communication, trust and regulation
3:12
The ethical challenges of AI in hematology: patient communication, trust and regulation
Adrián Mosquera Orgueira • 24 Sep 2026
The future of AI in hematology: personalized medicine, opportunities and risks
2:30
The future of AI in hematology: personalized medicine, opportunities and risks
Adrián Mosquera Orgueira • 24 Sep 2026
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
5:18
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
Shyam Patel • 13 Oct 2026
The scientific and clinical implications of therapy-related CHIP in oncology
2:43
The scientific and clinical implications of therapy-related CHIP in oncology
Shyam Patel • 13 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals